Jim Cramer’s Game Plan: 17 Stocks in Focus

Page 12 of 16

5. Hims & Hers Health, Inc. (NYSE:HIMS)

Number of Hedge Fund Holders: 38

Cramer highlighted the chatter around whether Hims & Hers Health, Inc. (NYSE:HIMS) will be able to offer cheaper alternatives to GLP-1 drugs.

“Finally, I have to tell you there’s one stock that’s become a true battleground here and I don’t mean Palantir. I’m talking about a stock called Hims & Hers Health. That’s an online healthcare company that currently offers a less expensive alternative to the GLP-1 weight loss drugs as long as they’re relatively unavailable. Now today the FDA said that Novo Nordisk GLP-1 formulation is no longer in short supply, which, which could mean that the compounding pharmacies that are making similar versions of the drug have to stop.

Now Hims & Hers has said it can still make the cheaper version some way, but the market seems skeptical. Hence the stock’s astounding 26% collapse today. But then again, it’s still up more than a 100% year to date so profit-taking… makes sense to me.”

Hims & Hers Health (NYSE:HIMS) offers a telehealth platform that delivers both prescription and over-the-counter health and wellness products and services, such as medication, skincare, sexual health, hair care, and wellness items, along with continuous support from licensed healthcare providers.

Page 12 of 16